GI
CGON icon

GAMMA Investing’s CG Oncology CGON Stock Holding History

GAMMA Investing’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9K Buy
731
+70
+11% +$4.58K ﹤0.01% 2271
2026
Q1 		$44.7K Buy
661
+150
+29% +$8.5K ﹤0.01% 2250
2025
Q4 		$21.2K Buy
511
+20
+4% +$828 ﹤0.01% 2579
2025
Q3 		$19.8K Sell
491
-40
-8% -$1.16K ﹤0.01% 2520
2025
Q2 		$13.8K Buy
531
+437
+465% +$10.5K ﹤0.01% 2650
2025
Q1 		$2.3K Sell
94
-106
-53% -$2.98K ﹤0.01% 3372
2024
Q4 		$5.74K Buy
200
+94
+89% +$3.22K ﹤0.01% 2859
2024
Q3 		$4K Buy
+106
New +$3.72K ﹤0.01% 2833

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMMA Investing's CGON Position: Q2 2026 in Review

GAMMA Investing increased its CG Oncology (CGON) stake by 11% in Q2 2026, buying an estimated $4.58K and bringing the position to 731 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

GAMMA Investing first reported a position in CGON in Q3 2024 and has held it in 8 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • GAMMA Investing held 731 shares of CG Oncology worth $51.9K as of Q2 2026.
  • GAMMA Investing bought 70 CG Oncology shares in Q2 2026, an estimated $4.58K.
  • CG Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2271 holding.
  • GAMMA Investing first reported a position in CG Oncology in Q3 2024 and has held it in 8 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.